These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20213121)

  • 1. Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy.
    Wood LM; Pan ZK; Shahabi V; Paterson Y
    Cancer Immunol Immunother; 2010 Jul; 59(7):1049-1058. PubMed ID: 20213121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability.
    Wallecha A; Wood L; Pan ZK; Maciag PC; Shahabi V; Paterson Y
    Clin Vaccine Immunol; 2013 Jan; 20(1):77-84. PubMed ID: 23136118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
    Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
    Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
    Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
    Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-attenuated Listeria-based immunotherapy.
    Rothman J; Paterson Y
    Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
    Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
    Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genetically Modified attenuated
    Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
    Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA; Chang MC; Sun WZ; Chen YL; Chiang YC; Hsieh CY; Chen SM; Hsiao PN; Cheng WF
    Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge.
    Zhang L; Wang S; Liu Z; Zhang L; Wang S; Wang B
    Int Immunopharmacol; 2017 Jun; 47():251-258. PubMed ID: 28445856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
    Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
    Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
    Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
    Maciag PC; Seavey MM; Pan ZK; Ferrone S; Paterson Y
    Cancer Res; 2008 Oct; 68(19):8066-75. PubMed ID: 18829565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11.
    Namkoong H; Song MY; Seo YB; Choi DH; Kim SW; Im SJ; Sung YC; Park Y
    Vaccine; 2014 Feb; 32(10):1205-12. PubMed ID: 23928465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.
    Karbach J; Neumann A; Atmaca A; Wahle C; Brand K; von Boehmer L; Knuth A; Bender A; Ritter G; Old LJ; Jäger E
    Clin Cancer Res; 2011 Feb; 17(4):861-70. PubMed ID: 21163871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo bactofection: listeria can function as a DNA-cancer vaccine.
    Souders NC; Verch T; Paterson Y
    DNA Cell Biol; 2006 Mar; 25(3):142-51. PubMed ID: 16569193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listeria-based cancer vaccines that segregate immunogenicity from toxicity.
    Brockstedt DG; Giedlin MA; Leong ML; Bahjat KS; Gao Y; Luckett W; Liu W; Cook DN; Portnoy DA; Dubensky TW
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13832-7. PubMed ID: 15365184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress.
    Lin CW; Lee JY; Tsao YP; Shen CP; Lai HC; Chen SL
    Int J Cancer; 2002 Dec; 102(6):629-37. PubMed ID: 12448006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.